Long-Term Assets: The sum of all assets classified as non-current.
Virax Biolabs Group Limited (VRAX) had Long-Term Assets of $1.54M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$4.89M |
|
$1.54M |
|
|
Long-Term Assets |
$1.54M |
$6.43M |
|
$0.67M |
|
-- |
|
-- |
|
$0.96M |
|
$5.46M |
|
$5.46M |
|
$5.46M |
|
-- |
|
| Cash Flow Statement Financials | |
$-4.56M |
|
$-0.60M |
|
$5.81M |
|
$3.59M |
|
$4.23M |
|
$0.64M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|